Product category:
Reference standards
News Release from: Lux Biotechnology
Edited by the Laboratorytalk Editorial
Team on 31 May 2007
Lux Biotechnology announces appointment
of COO
Specialist developer of light based detection technologies has announced the appointment of Bryan Smith as chief operating officer of the company
Bryan Smith joins the management team following over 12 years experience in operations and operational consulting Smith joins Lux from PricewaterhouseCoopers where his role as management consultant, included the delivery of operations and supply chain reviews to verify compliance with appropriate standards (including ISO and FDA) and identify opportunities for cost and service improvement
This article was originally published on Laboratorytalk on 27 Mar 2006 at 8.00am (UK)
Related stories
Award for development of fluorescent calibration
Following the success of the Glowell range of luminescent standards, Lux Biotechnology is branching out into fluorescent standards, offering a high quality and versatile range of products
Distribution of bioimaging luminescent standards
Lux Biotechnology, a developer of luminescence and fluorescence technologies, has a new partnership with UVP for the distribution of low light imaging standards (LLIS) in North America and Europe
He previously worked as a LeanSigma expert for GlaxoSmithKline within its global manufacturing and supply organisation, where he identified and managed step change projects delivering significantly lower operational costs and increased efficiency.
Prior to this, Smith had extensive experience in production management at SmithKline Beecham.
On joining Lux, Smith will manage all operations and will work to maximise the performance of its processes.
Lux's core competencies lie in the rapid development and commercialisation of technology with carefully selected partners.
The Edinburgh-based biotech company has seen rapid growth in the last 12 months along with demand for its solutions from diverse sectors including energy, chemical, water quality, medical and life science industries.
Artin Moussavi, CEO, stated: "We are delighted that Bryan has agreed to join Lux Biotechnology's management team.
"His experience and proven skills in managing operational change, quality and effectiveness is an extremely valuable addition to the team and help us to excel on a number of projects which will reach market in the next 18 months.
"As Lux continues to grow, Bryan will be well placed to lead the company's operations as we prepare to expand into the next phase of our development".
Bryan Smith stated: "I am very pleased to be joining Lux at this exciting stage in its development.
"I believe that Lux has the management team and the technology to succeed and become a leading organisation in the world renowned Scottish biotechnology cluster.".
• Lux Biotechnology: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
